IP Verse

Treatment Of Coccidiosis With Intramuscular Triazine Compositions - EP2928455

The patent EP2928455 was granted to Ceva Sant Animale on Aug 21, 2019. The application was originally filed on Dec 6, 2013 under application number EP13815401A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2928455

CEVA SANT ANIMALE
Application Number
EP13815401A
Filing Date
Dec 6, 2013
Status
Granted And Under Opposition
Jul 19, 2019
Grant Date
Aug 21, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELANCOJun 1, 2020POTTER CLARKSONWITHDRAWN
BAYER ANIMAL HEALTHMay 20, 2020VON RENESSEWITHDRAWN

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTDE102007025908
INTERNATIONAL-SEARCH-REPORTFR2946882
INTERNATIONAL-SEARCH-REPORTUS6465460
OPPOSITIONCA2699613
OPPOSITIONCN101947201
OPPOSITIONDE102007025908
OPPOSITIONUS4493826
OPPOSITIONUS6465460
OPPOSITIONWO2010146155

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- anonymous, "URSOFERRAN 150 mg/ml per os", Fachinformation, (201605), pages 1 - 5, URL: http://www.serumwerk.com/wp-content/uploads/2016/05/Ursoferran150-FI-12-14.pdf, XP055702024-
OPPOSITION- "Eisenmangelanämie", HEINRITZI et al., Schweinekrankheiten, Stuttgart, UTB, (20060000), pages 52 - 54, XP055702028-
OPPOSITION- EMEA, "Committee for veterinary medicinal products: Diaclayuril", EMEA/MRL/895/04-Final-rev, (20040500), pages 1 - 2, URL: n Place: URL: https://www.ema.europa.eu/en/documents/mrl-report/diclazuril-extension-all-ruminants-porcine-species-summary-report-2-committee-veterinary-medicinal_en.pdf https://www.ema.europa.eu/en/documents/mrl-report/diclazuril-extension-all-ruminants-porcine-species-summary-report-2-committee-veterinary-medicinal_en.pdf, XP055702021-
OPPOSITION- "Large Animal Dosage", MARK G. PAPICH, Handbook of Veterinary Drugs: Small and Large Animal. 3rd ed., Saunders, (20101100), XP055702016-
OPPOSITION- Pollmann Et Al., "Comparison of gleptoferron with iron dextran for anemia prevention in young pigs", Journal of Animal Science, (19830101), vol. 56, no. 3, pages 640 - 644, XP055453591-
OPPOSITION- EGELI A.K.; FRAMSTAD, T., "An evaluation of iron-dextran supplementation in piglets administered by injection on the first, third or fourth day after birth", RESEARCH IN VETERINARY SCIENCE., BRITISH VETERINARY ASSOCIATION, LONDON., GB, GB, (20020525), vol. 66, no. 3, doi:10.1053/rvsc.1998.0223, ISSN 0034-5288, pages 179 - 184, XP029581701
OPPOSITION- PAN B L et al., "Effect of subcutaneously administered diclauzuril on the output of Eimeria species oocysts by experimentally infected rabbits", The Veterinary Record, (20080202), vol. 162, no. 5, doi:10.1136/vr.162.5.153, XP009166529

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents